Skip to main content
. 2022 Mar 20;2022:3080263. doi: 10.1155/2022/3080263

Figure 3.

Figure 3

Metabolomic analysis of cisplatin-treated HEI-OC1 cells. (a) Heatmap of metabolites collected from HEI-OC1 cells with cisplatin (20 μM for 12 h) exposure. (b) Overview of enriched metabolite pathways (top 25). (Analyses of data were all conducted on http://www.metaboanalyst.ca. NC: control group treated with same dose of DMF in cisplatin group.).